Purchases and Sales Made in Q3 2022 in Stealth Bio Therapeutics Corp (MITO)
This table provides information about the institutional ownership of Stealth Bio Therapeutics Corp (MITO) during Q3 2022. The information is specifically focused on institutions that hold shares of Stealth BioTherapeutics Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
82.2K+ 556.4% |
$16.4K - $26.3K
|
96.9K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Envestnet Asset Management Inc
|
BUY
|
- |
5.4K+ 30.28% |
$1.08K - $1.73K
|
23.2K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
469+ 4.86% |
$93.8 - $150
|
10.1K
$0
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-1.7K- 11.04% |
$340 - $544
|
13.7K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-4.61K- 9.52% |
$921 - $1.47K
|
43.8K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-23.2K- 42.79% |
$4.64K - $7.42K
|
31K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-28K- 98.29% |
$5.61K - $8.97K
|
487
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-66.3K- 13.22% |
$13.3K - $21.2K
|
436K
$0
|